Evidence map›Paper›PMID 28266949›Full record

Trial reportMenopause (New York, N.Y.)2017

Efficacy of a biobehavioral intervention for hot flashes: a randomized controlled pilot study.

Debra L Barton, Kelliann C Fee Schroeder, Tanima Banerjee, Sherry Wolf, Timothy Z Keith, Gary Elkins

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Menopause (New York, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Management of menopausal hot flushes. Recommendations from the Spanish Menopause Society.European journal of obstetrics & gynecology and reproductive biology: X · 2025
    Review
  3. Review
  4. Complementary and Alternative Medicine for Menopause.Journal of evidence-based integrative medicine
    Review
  5. Review
  6. Review
  7. Oncology Advanced Practitioners and Breast Cancer Prevention.Journal of the advanced practitioner in oncology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Debra L Barton1University of Michigan, School of Nursing, Ann Arbor, MI 2Mayo Clinic, Rochester, MN 3University of Texas, Austin, TX 4Baylor University, Waco, TX.
Kelliann C Fee Schroeder
Tanima Banerjee
Sherry Wolf
Timothy Z Keith
Gary Elkins
Mayo Clinic in Arizona · USUniversity of Michigan–Ann Arbor · USBaylor University · USThe University of Texas at Austin · US

Funding

Evaluation of a biobehavioral intervention for hot flashesR21CA131795 · NCI · MAYO CLINIC ROCHESTER · PI BARTON, DEBRA L., ELKINS, GARY R · 2009 to 2010
$366k
NCI NIH HHS R21 CA131795
6 · The paper itself

Abstract

objectiveThe need for effective nonhormonal treatments for hot flash management without unwanted side effects continues. The primary aim of this pilot study was to evaluate the effect of combining a nonhormonal pharmacologic agent with a behavioral treatment for hot flash reduction.

methodsSeventy-one postmenopausal women were randomized to one of four groups: venlafaxine 75 mg + hypnosis (VH) versus venlafaxine 75 mg + sham hypnosis (VSH) versus a placebo pill + hypnosis (PH) versus placebo pill + sham hypnosis (PSH). Women recorded hot flash severity and frequency in a daily diary, in real time. The intrapatient difference in hot flash score (frequency × severity) at 8 weeks was analyzed using a General Estimating Equation model, using VSH as the referent arm, controlling for baseline hot flashes.

resultsThe active arms including PH or VH were not statistically significantly different than VSH (P = 0.34, P = 0.05, respectively). Women in each active arm reported hot flash reductions of about 50%, with the PSH group reporting a 25% reduction. Women receiving the PSH reported statistically significantly smaller reductions in hot flash score than women in the referent VSH arm (P = 0.001). There were no significant negative side effects during the course of the study.

conclusionsHypnosis alone reduced hot flashes equal to venlafaxine alone, but the combination of hypnosis and venlafaxine did not reduce hot flashes more than either treatment alone. More research is needed to clarify whether combining hypnosis with a different antidepressant would provide synergistic benefits.

Indexed as

Antidepressive Agents, Second-GenerationBiobehavioral SciencesCombined Modality TherapyDouble-Blind MethodFemaleHot FlashesHumansHypnosisMiddle AgedPilot ProjectsTreatment OutcomeVenlafaxine HydrochlorideAntidepressive Agents, Second-GenerationVenlafaxine Hydrochloride

Identifiers

PMID28266949
PMCPMC5747247
OpenAlexW2592706963

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.